CH592071A5 - - Google Patents

Info

Publication number
CH592071A5
CH592071A5 CH703673A CH703673A CH592071A5 CH 592071 A5 CH592071 A5 CH 592071A5 CH 703673 A CH703673 A CH 703673A CH 703673 A CH703673 A CH 703673A CH 592071 A5 CH592071 A5 CH 592071A5
Authority
CH
Switzerland
Application number
CH703673A
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of CH592071A5 publication Critical patent/CH592071A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
CH703673A 1972-05-18 1973-05-17 CH592071A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
CH592071A5 true CH592071A5 (en:Method) 1977-10-14

Family

ID=10195157

Family Applications (5)

Application Number Title Priority Date Filing Date
CH1621375A CH587834A5 (en:Method) 1972-05-18 1973-05-17
CH703673A CH592071A5 (en:Method) 1972-05-18 1973-05-17
CH1621275A CH595361A5 (en:Method) 1972-05-18 1973-05-17
CH1298576A CH595362A5 (en:Method) 1972-05-18 1973-05-17
CH1298676A CH594643A5 (en:Method) 1972-05-18 1973-05-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1621375A CH587834A5 (en:Method) 1972-05-18 1973-05-17

Family Applications After (3)

Application Number Title Priority Date Filing Date
CH1621275A CH595361A5 (en:Method) 1972-05-18 1973-05-17
CH1298576A CH595362A5 (en:Method) 1972-05-18 1973-05-17
CH1298676A CH594643A5 (en:Method) 1972-05-18 1973-05-17

Country Status (31)

Country Link
US (1) US3912748A (en:Method)
JP (6) JPS5912672B2 (en:Method)
KR (1) KR780000234B1 (en:Method)
AR (4) AR230991A1 (en:Method)
AT (1) AT333752B (en:Method)
BE (1) BE799790A (en:Method)
BG (1) BG21408A3 (en:Method)
CA (1) CA1029019A (en:Method)
CH (5) CH587834A5 (en:Method)
CS (1) CS200455B2 (en:Method)
CY (1) CY1016A (en:Method)
DD (1) DD105229A5 (en:Method)
DE (1) DE2324443A1 (en:Method)
DK (1) DK140340B (en:Method)
ES (1) ES414863A1 (en:Method)
FR (2) FR2184966B1 (en:Method)
GB (1) GB1435721A (en:Method)
HK (1) HK72579A (en:Method)
HU (1) HU167933B (en:Method)
IE (2) IE37564B1 (en:Method)
IL (2) IL42102A (en:Method)
KE (1) KE2975A (en:Method)
MY (1) MY8000063A (en:Method)
NL (1) NL170145C (en:Method)
PH (3) PH9685A (en:Method)
PL (3) PL89247B1 (en:Method)
RO (2) RO66800A (en:Method)
SE (3) SE386174B (en:Method)
SU (3) SU574157A3 (en:Method)
YU (3) YU130473A (en:Method)
ZA (1) ZA732791B (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
CA1125768A (en) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Benzoxazole derivatives
GR75153B (en:Method) * 1981-03-27 1984-07-13 Lilly Co Eli
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
ME01868B (me) * 2004-12-15 2010-10-31 Dompe Pha R Ma Spa Res & Mfg Derivati 2-arilpropionske kiseline i farmaceutske smeše, koje ih sadrže
CA2609659C (en) 2005-05-26 2014-01-28 Neuron Systems, Inc. Azanaphthalenes, compositions and methods for treating retinal disease
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
RU2018145691A (ru) 2013-01-23 2019-04-01 Альдейра Терапьютикс, Инк. Заболевания, связанные с токсичным альдегидом, и их лечение
MX2015009444A (es) 2013-01-25 2016-04-15 Aldeyra Therapeutics Inc Trampas novedosas en el tratamiento de la degeneracion macular.
JPWO2016021706A1 (ja) * 2014-08-08 2017-05-25 カズマパートナーズ株式会社 縮合複素環化合物
US10550085B2 (en) 2015-08-21 2020-02-04 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3113462A1 (en) 2018-09-25 2020-04-02 Aldeyra Therapeutics, Inc. Formulations of reproxalap for the treatment of dry eye disease
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス, インコーポレイテッド 眼科用製剤およびその使用
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (en:Method) *
NL285932A (en:Method) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL37633A (en) * 1970-09-10 1975-08-31 Merck & Co Inc 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen

Also Published As

Publication number Publication date
YU117079A (en) 1981-08-31
ATA432573A (de) 1976-04-15
HU167933B (en:Method) 1976-01-28
SE386174B (sv) 1976-08-02
SU574157A3 (ru) 1977-09-25
AR205021A1 (es) 1976-03-31
FR2184966B1 (en:Method) 1979-01-12
AR212010A1 (es) 1978-04-28
PL89247B1 (en:Method) 1976-11-30
PH9685A (en) 1976-02-10
NL7307018A (en:Method) 1973-11-20
AR230991A1 (es) 1984-08-31
DD105229A5 (en:Method) 1974-04-12
SU582762A3 (ru) 1977-11-30
AR207857A1 (es) 1976-11-08
SE7710602L (sv) 1977-09-21
AT333752B (de) 1976-12-10
JPS56167645A (en) 1981-12-23
CS200455B2 (en) 1980-09-15
SE434399B (sv) 1984-07-23
PL92565B1 (en:Method) 1977-04-30
NL170145C (nl) 1982-10-01
MY8000063A (en) 1980-12-31
ES414863A1 (es) 1976-02-01
KR780000234B1 (en) 1978-07-01
JPS56167675A (en) 1981-12-23
PL94208B1 (en:Method) 1977-07-30
IE37563B1 (en) 1977-08-17
SU580837A3 (ru) 1977-11-15
IL42102A0 (en) 1973-06-29
PH10704A (en) 1977-08-24
IL42102A (en) 1977-07-31
JPS4954363A (en:Method) 1974-05-27
HK72579A (en) 1979-10-19
IE37564B1 (en) 1977-08-17
DK140340C (en:Method) 1979-12-31
PH11718A (en) 1978-05-30
GB1435721A (en) 1976-05-12
YU36298B (en) 1982-06-18
ZA732791B (en) 1974-12-24
CA1029019A (en) 1978-04-04
CH587834A5 (en:Method) 1977-05-13
JPS56167673A (en) 1981-12-23
RO66800A (ro) 1982-03-24
IE37564L (en) 1973-11-18
CH595361A5 (en:Method) 1978-02-15
CH595362A5 (en:Method) 1978-02-15
RO66278A (ro) 1981-06-26
JPS56167674A (en) 1981-12-23
SE435838B (sv) 1984-10-22
BE799790A (fr) 1973-11-19
JPS5912672B2 (ja) 1984-03-24
JPS59161346A (ja) 1984-09-12
DE2324443A1 (de) 1973-11-29
YU130473A (en) 1981-08-31
BG21408A3 (bg) 1976-05-20
IL48711A0 (en) 1976-02-29
AU5590773A (en) 1974-11-21
KE2975A (en) 1979-07-20
NL170145B (nl) 1982-05-03
IE37563L (en) 1973-11-18
US3912748A (en) 1975-10-14
JPS5929185B2 (ja) 1984-07-18
JPS6021976B2 (ja) 1985-05-30
CH594643A5 (en:Method) 1978-01-13
FR2284592B1 (en:Method) 1979-01-05
FR2184966A1 (en:Method) 1973-12-28
FR2284592A1 (fr) 1976-04-09
YU117179A (en) 1981-08-31
SE7509387L (sv) 1975-08-22
DK140340B (da) 1979-08-06
CY1016A (en) 1979-11-23

Similar Documents

Publication Publication Date Title
CS152750B1 (en:Method)
CS156332B1 (en:Method)
CS158784B1 (en:Method)
CS159564B1 (en:Method)
CH587857A5 (en:Method)
CH587249A5 (en:Method)
BG20192A1 (en:Method)
CH1336273A4 (en:Method)
CH1527073A4 (en:Method)
CH559069A5 (en:Method)
CH559264A5 (en:Method)
CH559524A5 (en:Method)
CH560305A5 (en:Method)
CH560306A5 (en:Method)
CH560356A5 (en:Method)
CH560463A5 (en:Method)
CH560498A5 (en:Method)
CH563174A5 (en:Method)
CH563674A5 (en:Method)
CH564200A5 (en:Method)
CH568853A5 (en:Method)
CH589412A5 (en:Method)
CH569572A5 (en:Method)
CH569621A5 (en:Method)
CH569838A5 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased